// App-Quantinova.ai

: Development of a Robust BH3 Profiling Toolkit for Precision Medicine in Hematologic Malignancies

Researchers

Presenter

  • Valentin Jacquier

Principal Investigators

  • Antoine Guillemin

  • Sara Ovejero-Merino

  • Guilhem Requirand

  • Ouissem Karmous-Gadacha

  • Laure Dutrieux

  • Andrea Romero

  • Alizee Steer

  • Amelie Machura

  • Hugues De Boussac

  • Jerome Moreaux

  • Charles Herbaux

Medical Centers

  • UFR Médecine, Université Montpellier, Montpellier, France

  • CHU MONTPELLIER, MONTPELLIER, France

  • Institute of Human Genetics, UMR CNRS-UM, Montpellier, France

  • Laboratory for Monitoring Innovative Therapies, Department of Biological Hematology, CHU Montpellier, Montpellier, France

  • Institut Universitaire de France, Paris, France

  • DiagTec, Montpellier, France

  • Hematology Department, Montpellier University Hospital, Montpellier, France, Montpellier, France

Locations

  • France

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Hematological malignancies

Biomarkers

  • Annexin V

Drug/Treatment

  • Navitoclax

  • Venetoclax

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved